Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria
Ron Korstanje(Jackson Laboratory), Mario Schiffer(Universitätsklinikum Erlangen), Susan Sheehan(Jackson Laboratory), Konstantin Deutsch(Boston Children's Hospital), Jan Hinrich Bräsen(Universität Hamburg), Lynne Staggs(Mount Desert Island Biological Laboratory), Nils Hanke(University of Kassel), Ian S D Roberts(John Radcliffe Hospital), Hermann Haller(Mount Desert Island Biological Laboratory), Holly Savage(Jackson Laboratory), Patricia Schröder(Mount Desert Island Biological Laboratory), Patricia Bolaños-Palmieri(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 40
Related Papers
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
|Circulation|1999|671
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
|Nature Communications|2012|614
Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
|Journal of Clinical Oncology|2006|388
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
|The Lancet Oncology|2009|308
Deep Learning–Based Segmentation and Quantification in Experimental Kidney Histopathology
|Journal of the American Society of Nephrology|2020|177